Feature | June 24, 2014

New Study Develops Cutting-edge Echocardiography Method for Diagnosis of Acute Coronary Syndromes

June 24, 2014 — Researchers have announced the results of a clinical study that used a novel echocardiographic technique to detect and quantify damage to heart muscle even after an episode of mild cardiac injury from ischemia (low blood flow to the heart) has resolved. These findings provide hope for detecting potential heart attack victims before they experience life-threatening symptoms.

“The ability to detect heart damage due to low blood flow that occurs downstream from a coronary blockage is key to the early diagnosis of heart attack or for identifying patients who are at very high risk for heart attack,” said primary investigator Brian H. Mott, M.D. Mott is a cardiology research fellow at Oregon Health and Science University in Portland, Ore.; he and his colleagues used myocardial contrast echocardiography with custom-designed microbubble contrast agents, which can be injected through a simple IV and then bind to injured tissue to detect molecular changes that occurred up to six hours after very brief reduction in blood flow. “An issue is that our clinical tools for diagnosing threatened heart attack are far from perfect,” Mott commented. “Our approach using ‘smart’ targeted microbubbles could allow the clinician to detect problems at the bedside in just minutes. Moreover, the technique works to detect injury long after it has resolved and can be used to help judge patient risk according to the size of the area that is jeopardized by low blood flow.”

Researchers on the study, “Myocardial Contrast Echocardiography Molecular Imaging With Phosphatidylserine-enriched Microbubbles for Detection and Spatial Quantification of Myocardial Ischemia,” included Brian H. Mott, William H. Packwood, Brian P. Davidson and Jonathan R. Lindner from Oregon Health and Science University in Portland, Ore.

For more information: www.asecho.org

Related Content

warfarin, atrial fibrillation, kidney failure, HRS 2016
News | Antiplatelet and Anticoagulation Therapies| May 06, 2016
Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if anticoagulation levels...
SCAI 2016, PCI, bleeding risk, bivalirudin, NCDR risk calculator, clinical trial
News | Antiplatelet and Anticoagulation Therapies| May 06, 2016
The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in bleeding events for...
CSI, Cardiovascular Systems Inc, Diamondback 360 Coronary Orbital Atherectomy System, OAS, ORBIT II study, three-year results, SCAI 2016
News | Atherectomy Devices| May 06, 2016
May 6, 2016 — Cardiovascular Systems Inc.
TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Arterial Disease (PAD)| May 05, 2016
Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon Angioplasty – Below-...
American Society of Echocardiography, ASE guideline, left ventricular diastolic function, LV, heart failure, JASE
News | Cardiovascular Ultrasound| May 03, 2016
May 3, 2016 — Good news for clinicians and their patients: the evaluation of left ventricular (LV) diastolic function
radiation dose in the cath lab
News | Radiation Dose Management| May 02, 2016
May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May
microtubules, heartbeat mechanics, Perelman School of Medicine study

Microtubules in a cardiomyocyte at rest (top) and when compressed. Image courtesy of the lab of Ben Prosser, Ph.D., Perelman School of Medicine, University of Pennsylvania

News | EP Lab| April 29, 2016
Using new high-resolution microscopy, researchers have found that molecular struts called microtubules (MT) interact...
Konica Minolta, Sonimage HS1, version 3.0, compact ultrasound
Technology | Cardiovascular Ultrasound| April 28, 2016
Konica Minolta introduced the latest version of the Sonimage HS1 compact ultrasound system, enabling improved image...
breast cancer, herceptin chemotherapy drug, heart damage, monitoring, Journal of Clinical Oncology study
News | Cardiac Diagnostics| April 28, 2016
April 28, 2016 — Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored
coronary CT angiography, CCTA, SCOT-HEART trial substudy, SCCT
News | Computed Tomography (CT)| April 26, 2016
The results of a secondary analysis of the SCOT-HEART trial show that coronary computed tomography angiography (CCTA)...
Overlay Init